M. Hamza

Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

Deepak L. Bhatt, N. Sattar, D. McGuire, 2020, Journal of the American Heart Association.

Orally administered epeleuton inhibits SARS-CoV-2 viral load, replication and pathology in the Syrian Hamster model

P. Wohlsein, W. Baumgärtner, G. van Amerongen, 2021, bioRxiv.